Related Experiment Video
Updated: May 15, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
Delta-like 3 is silenced by methylation and induces apoptosis in human hepatocellular carcinoma
Kentaro Maemura1, Hirohide Yoshikawa, Kazutake Yokoyama
1Department of Anatomy and Cell Biology, Osaka Medical College, Takatsuki, Osaka, Japan. an2011@art.osaka-med.ac.jp
Abstract:
The genetic and epigenetic events of hepato-carcinogenesis are relatively poorly understood. By analyzing genes from human hepatocellular carcinoma (HCC) with restriction landmark genomic scanning, several aberrantly methylated genes, including Delta-like 3 (DLL3), have been isolated. In this study, we investigated the function of DLL3 in hepatocarcinogenesis. Methylation of the DLL3 gene in HCC cell lines was investigated with methylation-specific PCR and expression of DLL3 mRNA in HCC cells was examined by RT-PCR. Reactivation of DLL3 expression by treatment with a demethylating agent was examined in methylation-silenced HuH2 cells. Human DLL3 cDNA was cloned and DLL3 function was examined by restoring DLL3 expression in HuH2 cells. The effects of DLL3 on cell growth were evaluated by colony formation assay. Induction of cell death by overexpression of DLL3 was examined by flow cytometric assay using Annexin V and PI. Apoptotic cells were detected by TUNEL staining and the amount of single-stranded DNA was measured by ELISA. As a result, the promoter region of the DLL3 gene was methylated in four of ten HCC cell lines. This aberrant methyl-ation correlated well with the suppression of RNA expression and a demethylating agent reactivated DLL3 expression in methylation-silenced HCC cells. Interestingly, the restoration of DLL3 in the methylation-silenced HuH2 cells led to growth suppression on colony formation assay. Flow cytometric assay with Annexin V and PI showed that this growth suppression by DLL3 expression is associated with the induction of apoptosis. Furthermore, these apoptotic effects were confirmed by TUNEL staining and measurement of single-stranded DNA. These results suggest that DLL3 was silenced by methylation in human HCC and that it negatively regulates the growth of HCC cells.
Insights
Delta-like 3 (DLL3) gene methylation silences its expression in hepatocellular carcinoma (HCC). Restoring DLL3 expression suppresses HCC cell growth and induces apoptosis, revealing DLL3
Area of Science:
- Epigenetics
- Molecular Biology
- Cancer Research
Background:
- Hepatocellular carcinoma (HCC) development involves poorly understood genetic and epigenetic alterations.
- Aberrant gene methylation is a key epigenetic event in cancer, but its role in HCC is not fully elucidated.
- Delta-like 3 (DLL3) has been identified as a potentially methylated gene in HCC.
Purpose of the Study:
- To investigate the functional role of the DLL3 gene in hepatocarcinogenesis.
- To determine if DLL3 is epigenetically silenced by methylation in HCC.
- To assess the impact of DLL3 restoration on HCC cell growth and survival.
Main Methods:
- Methylation-specific PCR to detect DLL3 promoter methylation in HCC cell lines.
- RT-PCR to examine DLL3 mRNA expression levels.
- Treatment with a demethylating agent to reactivate silenced DLL3.
- Gene restoration studies by cloning human DLL3 cDNA and transfecting into HCC cells.
- Colony formation assays to evaluate cell growth.
- Flow cytometry (Annexin V/PI staining), TUNEL assay, and ELISA to assess apoptosis.
Main Results:
- DLL3 promoter methylation was observed in 40% of HCC cell lines analyzed.
- Aberrant methylation correlated with suppressed DLL3 mRNA expression.
- Demethylating agents reactivated DLL3 expression in silenced HCC cells.
- Restoration of DLL3 expression in methylation-silenced cells resulted in significant growth suppression.
- DLL3 overexpression induced apoptosis, confirmed by multiple assays.
Conclusions:
- DLL3 is epigenetically silenced by promoter methylation in a subset of human HCC.
- DLL3 functions as a tumor suppressor in HCC by inhibiting cell growth and inducing apoptosis.
- DLL3 represents a potential therapeutic target for HCC.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
